Brain Stem Cancer
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Brain Stem Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Brain Stem Cancer Local Doctors?
Distinguished in Brain Stem Cancer
Distinguished in Brain Stem Cancer

Carolinas Medical Center

1000 Blythe Blvd., 
Charlotte, NC 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Anthony Asher is a Neurosurgery provider practicing medicine in Charlotte, North Carolina. Dr. Asher is rated as a Distinguished provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 37 other conditions, according to our data. His clinical expertise encompasses Spondylolisthesis, Cervical Myelopathy, Brain Tumor, Laminectomy, and Spinal Fusion. Dr. Asher is board certified in American Board Of Neurological Surgery. Dr. Asher is currently accepting new patients.

Distinguished in Brain Stem Cancer
Neurosurgery
Distinguished in Brain Stem Cancer
Neurosurgery

OSF Illinois Neurological Institute - Neurosurgery

200 East Pennsylvania Avenue, 
Peoria, IL 
Languages Spoken:
English

Andrew Tsung is a Neurosurgery provider practicing medicine in Peoria, Illinois. Dr. Tsung is rated as a Distinguished provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Tsung is board certified in American Board Of Neurological Surgery.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Brain Stem Cancer
Advanced in Brain Stem Cancer

Texas Health Neurosurgery And Spine Specialists

800 5th Ave, Ste 500, 
Fort Worth, TX 
Languages Spoken:
English, Spanish

Dr. Harvey is a board-certified neurosurgeon with fellowship training in complex spine surgery. He also completed a one-year fellowship in neurosurgical oncology at The University of Texas MD Anderson Cancer Center in Houston. Dr. Harvey's area of special focus is the treatment of brain and spine tumors with additional interest in spinal cord trauma. He is an Arizona native who received his medical degree from the Arizona College of Osteopathic Medicine at Midwestern University in Glendale before completing his residency training in neurosurgery at the University of Illinois in Bloomington. As part of his residency, Harvey completed his complex spine fellowship at the University of Illinois Peoria. In addition to practicing medicine, he is a Major in the United States Army Reserve Medical Corps. He speaks Finnish and some Spanish. Dr. Harvey is rated as an Advanced provider by MediFind in the treatment of Brain Stem Cancer. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Subdural Hematoma, Chronic Subdural Hematoma, Delirium, Awake Craniotomy, and Vertebroplasty.

What are the latest Brain Stem Cancer Clinical Trials?
Phase I/II Study of Lutathera in Patients With Recurrent and/or Progressive High-Grade Central Nervous System Tumors and Meningiomas That Demonstrate Uptake on DOTATATE PET

Summary: This study will evaluate the safety and efficacy of Lutathera (177Lu-DOTATATE) in patients with progressive or recurrent High-Grade Central Nervous System (CNS) tumors and meningiomas that demonstrate uptake on DOTATATE PET. The drug will be given intravenously once every 8 weeks for a total of up to 4 doses over 8 months in patients aged 4 to \<12 years (Phase I) or 12 to \

Match to trials
Find the right clinical trials for you in under a minute
Get started
Phase 1 Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors

Summary: This is a Phase 1 study of central nervous system (CNS) locoregional adoptive therapy with autologous CD4+ and CD8+ T cells lentivirally transduced to express a B7H3-specific chimeric antigen receptor (CAR) and EGFRt. CAR T cells are delivered via an indwelling catheter into the tumor resection cavity or ventricular system in children and young adults with diffuse intrinsic pontine glioma (DIPG), ...